Adjuvant Chemotherapy for Non-small Cell Lung Cancer: Practice Patterns and Outcomes in the General Population of Ontario, Canada
- 1 March 2012
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 7 (3) , 559-566
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Adoption of Adjuvant Chemotherapy for Non–Small-Cell Lung Cancer: A Population-Based Outcomes StudyJournal of Clinical Oncology, 2010
- Adjuvant Cisplatin and Vinorelbine for Completely Resected Non-small Cell Lung Cancer: Subgroup Analysis of the Lung Adjuvant Cisplatin EvaluationJournal of Thoracic Oncology, 2010
- Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative GroupJournal of Clinical Oncology, 2008
- Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trialThe Lancet Oncology, 2006
- Adjuvant Chemotherapy for Resected Non-small Cell Lung CancerJournal of Thoracic Oncology, 2006
- Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005
- Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancerLung Cancer, 2005
- Socioeconomic status and cancer survival in Ontario.Journal of Clinical Oncology, 1997
- An application of capture-recapture methods to the estimation of completeness of cancer registrationJournal of Clinical Epidemiology, 1988
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987